Predictive, Prognostic Biomarkers Continue to Enhance Treatment Decisions in NSCLC
Isabel Preeshagul, DO, MBS, discusses encouraging updates with molecular drivers in non–small cell lung cancer and her advice to community oncologists treating patients.
Source: OncLive